D. Boral Capital initiated coverage of Pulmonx (LUNG) with a Buy rating and $17 price target The firm says Pulmonx is a commercial-stage medical technology company developing minimally invasive ...

Shares of Pulmonx Co. (NASDAQ:LUNG – Get Free Report) have earned a consensus rating of “Moderate Buy” from the six brokerages that are presently covering the stock, MarketBeat reports.

Pulmonx Stock Performance LUNG opened at $7.48 on Monday. The company has a current ratio of 7.70, a quick ratio of 6.77 and a debt-to-equity ratio of 0.40. Pulmonx Co. has a 12-month low of $5.46 ...

Ross Stores announced Monday it opened 16 Ross Dress for Less and three DD's Discounts stores in 14 states in March. According to the discount retailer, these new locations are part of the company ...

Revenue: US$83.8m (up 22% from FY 2023). Net loss: US$56.4m (loss narrowed by 7.3% from FY 2023). US$1.44 loss per share (improved from US$1.60 loss in FY 2023). Revenue exceeded analyst estimates ...

2025 Operating Expenses Guidance: Between $133 million and $135 million. Pulmonx Corp (NASDAQ:LUNG) reported a 23% increase in worldwide sales for Q4 2024, reaching $23.8 million, driven by strong ...

Pulmonx achieved Q4 2024 worldwide revenue of $23.8 million, a 23% increase year-over-year, driven by U.S. sales of $15.9 million and international sales of $7.9 million, which grew 16% and 42% ...

Ross Stores said Monday it has added 19 locations to its footprint this month. The new locations consisted of 16 of its Ross Dress for Less stores and a trio of dd’s Discounts stores ...

Ladies and gentlemen, thank you for standing by. Welcome to Pulmonx Fourth Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers ...